| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c17012 _d17012 |
||
| 001 | BD-DhNSU-17012 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403061827.0 | ||
| 008 | 190403s1991 nyua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a0824784847 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRM301.45 _b.P454 1991 |
| 082 | 0 | 0 |
_a615.58 _bP494 |
| 245 | 0 | 0 |
_aPharmaceutical bioequivalence / _cedited by Peter G. Welling, Francis L.S. Tse and Shrikant V. Dighe |
| 260 |
_aNew York : _bMarcel Dekker, _cc1991. |
||
| 300 |
_aix, 467 p. : _bill. ; _c23 cm. |
||
| 490 | 1 | _aDrugs and the pharmaceutical sciences ; v. 48 | |
| 650 | 0 | _aDrugs | |
| 650 | 4 | _aTherapeutic equivalency | |
| 650 | 4 | _aDrugs | |
| 700 | 1 | _aWelling, Peter G. | |
| 700 | 1 | _aTse, Francis L.S. | |
| 700 | 1 | _aDighe, Shrikant V. | |
| 942 |
_2lcc _cBK |
||